Skip to main content
ST PHARM CO., LTD. logo

ST PHARM CO., LTD. — Investor Relations & Filings

Ticker · 237690 ISIN · KR7237690003 KO Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2024-03-25 Board/Management Inform…
Country KR South Korea
Listing KO 237690

About ST PHARM CO., LTD.

https://www.stpharm.co.kr/en

ST PHARM CO., LTD. is a global Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs). The company provides technology-driven manufacturing services for gene therapies, with core expertise in oligonucleotides and various forms of RNA (xRNA), including messenger RNA (mRNA). In addition to nucleic acid-based medicines, ST Pharm offers custom manufacturing for small molecule APIs. The company's services operate under cGMP (current Good Manufacturing Practice) standards, providing comprehensive solutions that support the entire drug development lifecycle, from research and development to commercial-scale production for its global pharmaceutical partners.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사). This falls under the category of changes in the board of directors or senior management.
2024-03-25 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to specific employees/executives, including the number of shares, exercise price, and legal basis (Articles of Incorporation). This type of disclosure regarding capital structure changes and equity-based compensation is classified as a 'Share Issue/Capital Change' announcement in the provided schema.
2024-03-25 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Supervisory Service/Korea Exchange. It details the specific terms of stock option grants, including the number of shares, exercise price, vesting conditions, and the legal basis under the company's articles of incorporation. This type of disclosure regarding capital structure changes and equity-based compensation is classified as a 'Share Issue/Capital Change' (SHA) filing in the provided schema.
2024-03-25 Korean
투자판단관련주요경영사항(임상시험계획변경승인신청) (에이즈치료제 STP0404 임상 2a상 임상시험 계획 변경승인신청)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure filed by ST Pharm regarding a change in their clinical trial plan (STP0404) submitted to the US FDA. It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) in the Korean stock market (KRX). Since it does not fit into specific categories like financial reports, dividends, or board changes, and is a mandatory regulatory disclosure of material information, it is classified as a Regulatory Filing (RNS).
2024-03-21 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding the scheduling and details of an upcoming Investor Relations (IR) event (a Non-Deal Roadshow). It provides the date, location, and purpose of the meeting, and mentions that IR materials will be posted on the company's website. Since this is an announcement of an event and the availability of materials rather than the presentation itself, it falls under the category of a regulatory filing announcement.
2024-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion (unqualified/proper) and key financial data (assets, liabilities, revenue, profit) for the fiscal year. While it contains financial data, it is a standard regulatory announcement form used to notify the market that the audit report has been received and filed, rather than the full, multi-page audit report document itself. Therefore, it falls under the category of a regulatory filing announcement. FY 2023
2024-03-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.